Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Amortization of Deferred Charges (2019 - 2025)

Historic Amortization of Deferred Charges for Wave Life Sciences (WVE) over the last 7 years, with Q3 2025 value amounting to $1.4 million.

  • Wave Life Sciences' Amortization of Deferred Charges rose 1355.37% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 1350.94%. This contributed to the annual value of $4.8 million for FY2024, which is 1333.81% up from last year.
  • According to the latest figures from Q3 2025, Wave Life Sciences' Amortization of Deferred Charges is $1.4 million, which was up 1355.37% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Wave Life Sciences' Amortization of Deferred Charges registered a high of $1.4 million during Q3 2025, and its lowest value of $512000.0 during Q1 2021.
  • For the 5-year period, Wave Life Sciences' Amortization of Deferred Charges averaged around $992578.9, with its median value being $1.0 million (2023).
  • As far as peak fluctuations go, Wave Life Sciences' Amortization of Deferred Charges skyrocketed by 7527.27% in 2022, and later surged by 1068.46% in 2023.
  • Over the past 5 years, Wave Life Sciences' Amortization of Deferred Charges (Quarter) stood at $759000.0 in 2021, then grew by 29.51% to $983000.0 in 2022, then rose by 12.0% to $1.1 million in 2023, then rose by 13.44% to $1.2 million in 2024, then increased by 10.01% to $1.4 million in 2025.
  • Its Amortization of Deferred Charges stands at $1.4 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.3 million for Q1 2025.